Erica Dun, MD
Obstetrics & Gynecology · New York, NYNPI 1619032745
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,969 of the $2,809 with a category attached, or 70.1%. Intuitive Surgical accounts for 76.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $1,289 and has fallen 89.3% since, to $138 in 2025.
Across 31 payments — averaging $90.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Gynesonics, Inc.$200
- Myovant Sciences Inc.$129
- AbbVie$118
- Avion Pharmaceuticals$48
- Aesculap, Inc.$40
- plus $139 from 5 others
What the payments were for
- Consulting fees$2007%
- Travel & lodging$1,96970%
- Food & beverage$64023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $2,135 |
| Gynesonics, Inc. | 1 | $200 |
| Myovant Sciences Inc. | 2 | $129 |
| AbbVie | 1 | $118 |
| Avion Pharmaceuticals | 3 | $48 |
| Aesculap, Inc. | 1 | $40 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Astellas Pharma US Inc | 1 | $34 |
| Biogen | 1 | $30 |
| Coopersurgical, Inc. | 1 | $18 |
| Covidien LP | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,809 in reported general payments places this provider in the 85th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 43 | $3,585 |
| Misoprostol | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New York
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
- Melanie MarinNew York$123K
- Amitasrigowri MurthyNew York$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.